According to sources close to the talks, a deal on an intellectual property waiver for COVID-19 vaccines at the World Trade Organization (WTO) was no closer to acceptance on Monday despite backing from the US, due to expected scepticism about a new draft
People familiar with the matter say that since the US decided recently to back a proposed patent waiver on COVID-19 vaccines, pharmaceutical trade groups have been moving to support Germany, that have expressed opposition to the idea